Initial high dose chemotherapy plus autologous stem cell support improves survival outcomes compared with a standard CHOP regimen in people with higher intermediate risk aggressive lymphoma: Abstracted from: Milpied N, Deconinck E, Gaillard F, et al. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support. N Engl J Med 2004;350:1287–95.

✍ Scribed by Axel Glasmacher

• Book ID: 116394909
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 245 KB
• Volume: 30
• Category: Article
• ISSN: 0305-7372
• DOI: 10.1016/j.ctrv.2004.06.004